Evidence map›Paper›PMID 19843221›Full record

ArticleMolecular microbiology2009

Direct activator/co-activator interaction is essential for bacteriophage T4 middle gene expression.

Andy H Yuan, Ann Hochschild

Open access · greenAbstract read
In one paragraph

Article in Molecular microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Structural basis of σ appropriation.Nucleic acids research · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andy H YuanDepartment of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Ave., D1, Boston, MA 02115, USA.
Ann Hochschild
Harvard University · US

Funding

PROTEIN/PROTEIN INTERACTIONS IN PROKARYOTIC GENE CONTROLR01GM044025 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI HOCHSCHILD, ANN · 1990 to 2015
$8.1M
NIGMS NIH HHS R01 GM044025
6 · The paper itself

Abstract

The bacteriophage T4 AsiA protein is a bifunctional regulator that inhibits transcription from the major class of bacterial promoters and also serves as an essential co-activator of transcription from T4 middle promoters. AsiA binds the primary s factor in Escherichia coli, sigma(70), and modifies the promoter recognition properties of the sigma(70)-containing RNA polymerase(RNAP) holoenzyme. In its role as co-activator, AsiA directs RNAP to T4 middle promoters in the presence of the T4-encoded activator MotA. According to the current model for T4 middle promoter activation, AsiA plays an indirect role in stabilizing the activation complex by facilitating interaction between DNA-bound MotA and sigma(70). Here we show that AsiA also plays a direct role in T4 middle promoter activation by contacting the MotA activation domain. Furthermore,we show that interaction between AsiA and the beta-flap domain of RNAP is important for co-activation. Based on our findings, we propose a revised model for T4 middle promoter activation, with AsiA organizing the activation complex via three distinct protein-protein interactions.

Indexed as

Gene Expression Regulation, ViralTranscriptional ActivationBacteriophage T4DNA-Binding ProteinsDNA, ViralModels, BiologicalPromoter Regions, GeneticProtein BindingRNA-Dependent RNA PolymeraseTranscription FactorsViral ProteinsDNA-Binding ProteinsDNA, ViralMotA protein, Enterobacteria phage T4RNA-Dependent RNA PolymeraseTranscription FactorsViral Proteins

Identifiers

PMID19843221
PMCPMC5673250
OpenAlexW1587481278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.